Clinical Trials | October 03, 2023
Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
New Board of Directors and management team at Suven Pharma also appointed
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
30 beneficiaries avail of services per minute
Mankind Pharma commences the commercial operations newly set-up plant in Udaipur
Lupin has been exclusively marketing these brands in the Indian market since July 2021
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
Subscribe To Our Newsletter & Stay Updated
